The UCLA Cardiovascular Research Theme provides cardiac muscle cells as a core service at a highly subsidized rate. The goal of this service is to provide a readily available resource of cardiac muscle cells for investigators performing ex vivo experiments on cardiac muscle cells. Two types of cardiac muscle cells will be provided:

  1. Neonatal rat ventricular cardiomyocytes. These cells beat in the dish for 3-7 days and provide a platform for determining effects of toxins, drugs or other genetic manipulation of the cardiac muscle cell.
  2. Human embryonic stem cell or human iPSC derived cardiomyocytes. H9 or other NIH approved lines and UCLA approved lines are used as a source for the differentiation of cardiac muscle cells. Human pluripotent stem cell derived cardiac muscle cells will be handed to investigators at their preferred time point of differentiation. To maintain consistency, standard differentiation programs are used. Crispr/Cas edited hPSC derived cardiomyocytes will be introduced as a core service in the near future.

For more information, please visit the Cardiovascular Research Theme Cardiac Muscle Cell Core site.

Last updated
September 27, 2023